![[-]](data:image/gif;base64,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)
![[+]](data:image/gif;base64,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)
Data Entry
No Data Element Selected
Organisation Unit
Data Set
Period
Funding Mechanism
Filter on section
Quarterly Reporting
Semiannually Reporting
Annually Reporting
- Prevention
- Testing Path 1 - Top Line HTS_TST
- Testing Path 2 - HTS_TST Modalities
- Testing - All Others
- Treatment
- Viral Suppression
- Health Systems
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
DSD: PrEP_NEW
Auto-Calculate
Number of individuals who were newly enrolled on pre-exposure prophylaxis (PrEP) to prevent HIV infection in the reporting period. Numerator will auto-calculate from the Age/Sex Disaggregates.
Numerator
Required
Disaggregated by Age / Sex
Female
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Optional
Disaggregated by Pregnant/Breastfeeding Status: Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
Optional
Disaggregated by PrEP Distribution. Data on PrEP Distribution should be reported in both the "Disaggregated by PrEP Distribution" section and the "Disaggregated by Age/Sex" section.
Facility
Community
(Associated with Facility)
(Associated with Facility)
Optional
Disaggregated by PrEP Type. Data on PrEP Type should be reported in both the "Disaggregated by PrEP Type" section and the "Disaggregated by Age/Sex" section.
Oral
Injectable
Other
DSD: PrEP_CT
Auto-Calculate
Number of individuals, excluding those newly enrolled, that return for a follow-up visit or reinitiation visit to receive pre-exposure prophylaxis (PrEP) to prevent HIV during the reporting period. Numerator will auto-calculate from sum of Age/Sex Disaggregate
Numerator
Optional
Disaggregated by Age/Sex
Female
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Optional
Disaggregated by test result: Data on test result should be reported in both the "Test Result" section and the "Disaggregated by Age/Sex" section.
Positive
Negative
Other
Optional
Disaggregated by Pregnant/Breastfeeding: Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
Optional
Disaggregated by PrEP Distribution. Data on PrEP Distribution should be reported in both the "Disaggregated by PrEP Distribution" section and the "Disaggregated by Age/Sex" section.
Facility
Community
(Associated with Facility)
(Associated with Facility)
Optional
Disaggregated by PrEP Type. Data on PrEP Type should be reported in both the "Disaggregated by PrEP Type" section and the "Disaggregated by Age/Sex" section.
Oral
Injectable
Other
DSD: TB_PREV (Numerator)
Auto-Calculate
Among those who started a course of TPT in the previous reporting period, the number that completed a full course of therapy (for continuous IPT programs, this includes the patients who have completed the first 6 months of isoniazid preventive therapy (IPT), or any other standard course of TPT such as 3 months of weekly isoniazid and rifapentine, or 3-HP)
Numerator
Optional
Disaggregated By ART Start by Age/Sex
Newly enrolled on ART
Previously Enrolled on ART
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
DSD: TB_PREV (Denominator)
Auto-Calculate
Number of ART patients who were initiated on any course of TPT during the previous reporting period
Denominator
Optional
Disaggregated By ART Start by Age/Sex
Newly enrolled on ART
Previously Enrolled on ART
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
DSD: OVC_SERV
Auto-Calculate
Number of beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS. Numerator will auto-calculate from the sum of the OVC Comprehensive, DREAMS, and OVC Preventive disaggregates. Beneficiaries should only be entered in one of the three disaggregates.
Numerator
Optional
OVC Comprehensive. Disaggregated by Program Status (Active and Graduated) by age/sex and OVC/Caregiver. Beneficiaries entered here should not be counted in DREAMS or Preventive.
Active (Received at least one service in each of the preceding two quarters)
OVC: Female
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Female
18+
OVC: Male
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Male
18+
Subtotal (Active OVCs and Caregivers):
Graduated (At Q2: Graduated in the past 6 months. At Q4: Report the number of children and parents/caregivers that graduated in the past four quarters.)
Female
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Female
18+
Male
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Male
18+
Subtotal (Graduated OVCs and Caregivers):
Subtotal (All OVC Comprehensive OVCs and Caregivers):
Optional
Disaggregated by Transferred or Exited. (At Q2: Report exits or transfers within the past 6 months. At Q4: Report the number of exits or transfers in the past four quarters that did not return to active status or graduate.)
Transferred out to a PEPFAR-supported partner.
Transferred out to a non-PEPFAR supported partner.
Exited without Graduation.
Optional
DREAMS. Disaggregated by Age. Beneficiaries entered here should not be counted in OVC Comprehensive or Preventive. At Q2: Report AGYW that received an eligible OVC intervention in the previous two quarters. At Q4: Report AGYW that received an eligible OVC intervention in the past four quarters.
Female
Unknown Age
10-14
15-17
Subtotal (DREAMS):
Optional
OVC Preventive. Disaggregated by Age/Sex. Beneficiaries entered here should not be counted in OVC Comprehensive or DREAMS. At Q2: Report the number of children that have completed an approved primary prevention intervention in the past two quarters. At Q4: Report the number of children that have completed an approved primary prevention intervention in the past four quarters.
Unknown Age
5-9
10-14
Female
Male
Subtotal (OVC Preventive):
DSD: POST_RESP
Auto-Calculate
Number of people receiving post-sexual, physical and emotional violence (SPEV) clinical care based on the minimum package. Numerator will auto-calculate from the Violence Service Type Disaggregates
Numerator
Auto-Calculate
Disaggregated by Violence Service Type. Violence Service Types will auto-calculate from their respective age / sex disaggregates.
Sexual Violence
Physical and / or Emotional Violence
Optional
Disaggregated by Violence Service Type / Age / Sex
Sexual Violence
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Physical and / or Emotional Violence
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Optional
Disaggregate of Sexual Violence
Number of people receiving PEP Service
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Sub-total
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
TA-SDI: PrEP_NEW
Auto-Calculate
Number of individuals who were newly enrolled on pre-exposure prophylaxis (PrEP) to prevent HIV infection in the reporting period. Numerator will auto-calculate from the Age/Sex Disaggregates.
Numerator
Required
Disaggregated by Age / Sex
Female
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Optional
Disaggregated by Pregnant/Breastfeeding Status: Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
Optional
Disaggregated by PrEP Distribution. Data on PrEP Distribution should be reported in both the "Disaggregated by PrEP Distribution" section and the "Disaggregated by Age/Sex" section.
Facility
Community
(Associated with Facility)
(Associated with Facility)
Optional
Disaggregated by PrEP Type. Data on PrEP Type should be reported in both the "Disaggregated by PrEP Type" section and the "Disaggregated by Age/Sex" section.
Oral
Injectable
Other
TA-SDI: PrEP_CT
Auto-Calculate
Number of individuals, excluding those newly enrolled, that return for a follow-up visit or reinitiation visit to receive pre-exposure prophylaxis (PrEP) to prevent HIV during the reporting period. Numerator will auto-calculate from sum of Age/Sex Disaggregate
Numerator
Optional
Disaggregated by Age/Sex
Female
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Optional
Disaggregated by test result: Data on test result should be reported in both the "Test Result" section and the "Disaggregated by Age/Sex" section.
Positive
Negative
Other
Optional
Disaggregated by Pregnant/Breastfeeding: Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
Optional
Disaggregated by PrEP Distribution. Data on PrEP Distribution should be reported in both the "Disaggregated by PrEP Distribution" section and the "Disaggregated by Age/Sex" section.
Facility
Community
(Associated with Facility)
(Associated with Facility)
Optional
Disaggregated by PrEP Type. Data on PrEP Type should be reported in both the "Disaggregated by PrEP Type" section and the "Disaggregated by Age/Sex" section.
Oral
Injectable
Other
TA-SDI: TB_PREV (Numerator)
Auto-Calculate
Among those who started a course of TPT in the previous reporting period, the number that completed a full course of therapy (for continuous IPT programs, this includes the patients who have completed the first 6 months of isoniazid preventive therapy (IPT), or any other standard course of TPT such as 3 months of weekly isoniazid and rifapentine, or 3-HP)
Numerator
Optional
Disaggregated By ART Start by Age/Sex
Newly enrolled on ART
Previously Enrolled on ART
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
TA-SDI: TB_PREV (Denominator)
Auto-Calculate
Number of ART patients who were initiated on any course of TPT during the previous reporting period
Denominator
Optional
Disaggregated By ART Start by Age/Sex
Newly enrolled on ART
Previously Enrolled on ART
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
TA-SDI: OVC_SERV
Auto-Calculate
Number of beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS. Numerator will auto-calculate from the sum of the OVC Comprehensive, DREAMS, and OVC Preventive disaggregates. Beneficiaries should only be entered in one of the three disaggregates.
Numerator
Optional
OVC Comprehensive. Disaggregated by Program Status (Active and Graduated) by age/sex and OVC/Caregiver. Beneficiaries entered here should not be counted in DREAMS or Preventive.
Active (Received at least one service in each of the preceding two quarters)
OVC: Female
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Female
18+
OVC: Male
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Male
18+
Subtotal (Active OVCs and Caregivers):
Graduated (At Q2: Graduated in the past 6 months. At Q4: Report the number of children and parents/caregivers that graduated in the past four quarters.)
Female
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Female
18+
Male
Unknown Age
<1
1-4
5-9
10-14
15-17
18-20
Caregivers: Male
18+
Subtotal (Graduated OVCs and Caregivers):
Subtotal (All OVC Comprehensive OVCs and Caregivers):
Optional
Disaggregated by Transferred or Exited. (At Q2: Report exits or transfers within the past 6 months. At Q4: Report the number of exits or transfers in the past four quarters that did not return to active status or graduate.)
Transferred out to a PEPFAR-supported partner.
Transferred out to a non-PEPFAR supported partner.
Exited without Graduation.
Optional
DREAMS. Disaggregated by Age. Beneficiaries entered here should not be counted in OVC Comprehensive or Preventive. At Q2: Report AGYW that received an eligible OVC intervention in the previous two quarters. At Q4: Report AGYW that received an eligible OVC intervention in the past four quarters.
Female
Unknown Age
10-14
15-17
Subtotal (DREAMS):
Optional
OVC Preventive. Disaggregated by Age/Sex. Beneficiaries entered here should not be counted in OVC Comprehensive or DREAMS. At Q2: Report the number of children that have completed an approved primary prevention intervention in the past two quarters. At Q4: Report the number of children that have completed an approved primary prevention intervention in the past four quarters.
Unknown Age
5-9
10-14
Female
Male
Subtotal (OVC Preventive):
TA-SDI: POST_RESP
Auto-Calculate
Number of people receiving post-sexual, physical and emotional violence (SPEV) clinical care based on the minimum package. Numerator will auto-calculate from the Violence Service Type Disaggregates
Numerator
Auto-Calculate
Disaggregated by Violence Service Type. Violence Service Types will auto-calculate from their respective age / sex disaggregates.
Sexual Violence
Physical and / or Emotional Violence
Optional
Disaggregated by Violence Service Type / Age / Sex
Sexual Violence
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Physical and / or Emotional Violence
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Optional
Disaggregate of Sexual Violence
Number of people receiving PEP Service
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Sub-total
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
Use Testing Path 1 below to enter Top Line HTS_TST numerator by age/sex/result.
DSD: HTS_TST (Facility)
Auto-Calculate
Number of individuals who received HIV Testing Services (HTS) and received their test results.
Numerator
Positive
DSD: HTS_TST TOP LINE
Required
Age/Sex/Result - If HTS_TST data cannot be disaggregated by modality, please report ALL HTS_TST data here, under 'Top Line' by age, sex, result
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: PMTCT_STAT (Numerator)
Auto-Calculate
Number of pregnant women with known HIV status at first antenatal care visit (ANC1) (includes those who already knew their HIV status prior to ANC1). Numerator will auto-calculate from the Status and Age Disaggregates.
Numerator
Required
REQUIRED IF ON PATH 1. Disaggregated by Status and Age
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Known Positives:
Newly Tested Positives:
New Negatives:
Recent Negatives:
Sub-total
DSD: PMTCT_STAT (Denominator)
Auto-Calculate
Number of new ANC clients in reporting period. Denominator will auto-calculate from the Age Disaggregates.
Denominator
Required
REQUIRED IF ON PATH 1. Disaggregated by Age (Fine Disaggregate)
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Sub-total
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
Use Testing Path 1 below to enter Top Line HTS_TST numerator by age/sex/result.
TA-SDI: HTS_TST (Facility)
Auto-Calculate
Number of individuals who received HIV Testing Services (HTS) and received their test results.
Numerator
Positive
TA-SDI: HTS_TST TOP LINE
Required
Age/Sex/Result - If HTS_TST data cannot be disaggregated by modality, please report ALL HTS_TST data here, under 'Top Line' by age, sex, result
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: PMTCT_STAT (Numerator)
Auto-Calculate
Number of pregnant women with known HIV status at first antenatal care visit (ANC1) (includes those who already knew their HIV status prior to ANC1). Numerator will auto-calculate from the Status and Age Disaggregates.
Numerator
Required
REQUIRED IF ON PATH 1. Disaggregated by Status and Age
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Known Positives:
Newly Tested Positives:
New Negatives:
Recent Negatives:
Sub-total
TA-SDI: PMTCT_STAT (Denominator)
Auto-Calculate
Number of new ANC clients in reporting period. Denominator will auto-calculate from the Age Disaggregates.
Denominator
Required
REQUIRED IF ON PATH 1. Disaggregated by Age (Fine Disaggregate)
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Sub-total
Use Testing Path 1 below to enter Top Line HTS_TST numerator by age/sex/result.
CS: HTS_TST (Facility)
Auto-Calculate
Number of individuals who received HIV Testing Services (HTS) and received their test results.
Numerator
Positive
CS: HTS_TST TOP LINE
Required
Age/Sex/Result - If HTS_TST data cannot be disaggregated by modality, please report ALL HTS_TST data here, under 'Top Line' by age, sex, result.
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: PMTCT_STAT (Numerator)
Auto-Calculate
Number of pregnant women with known HIV status at first antenatal care visit (ANC1) (includes those who already knew their HIV status prior to ANC1). Numerator will auto-calculate from the Status and Age Disaggregates.
Numerator
Required
REQUIRED IF ON PATH 1. Disaggregated by Status and Age
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Known Positives:
Newly Tested Positives:
New Negatives:
Recent Negatives:
Sub-total
CS: PMTCT_STAT (Denominator)
Auto-Calculate
Number of new ANC clients in reporting period. Denominator will auto-calculate from the Age Disaggregates.
Denominator
Required
REQUIRED IF ON PATH 1. Disaggregated by Age (Fine Disaggregate)
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Sub-total
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
Use Testing Path 2 below to enter HTS_TST results by modalities.
DSD: HTS_TST (Facility)
Auto-Calculate
Number of individuals who received HIV Testing Services (HTS) and received their test results.
Numerator
Positive
DSD: PMTCT_STAT (Numerator)
Auto-Calculate
Number of pregnant women with known HIV status at first antenatal care visit (ANC1) (includes those who already knew their HIV status prior to ANC1). Numerator will auto-calculate from the Status and Age Disaggregates.
Numerator
Required
REQUIRED IF ON PATH 2. Disaggregated by Status and Age
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Known Positives:
Newly Tested Positives:
New Negatives:
Recent Negatives:
Sub-total
DSD: PMTCT_STAT (Denominator)
Auto-Calculate
Number of new ANC clients in reporting period. Denominator will auto-calculate from the Age Disaggregates.
Denominator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age (Fine Disaggregate)
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Sub-total
DSD: HTS_INDEX (Facility)
Auto-Calculate
Number of individuals who were identified and tested using index testing services and received their results. Numerator auto-calculates from the sum of the Number of contacts tested by test result and age/sex.
Numerator
Optional
Number of index cases offered index testing services by age/sex
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Optional
Number of index cases that accepted index testing services by age/sex
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Optional
Number of contacts elicited by age/sex
Unknown
Age
Age
<15
15+
Female
Male
Sub-Total
Required
REQUIRED IF ON PATH 2. Number of contacts tested by test result and age/sex
Newly Tested Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
New Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Optional
Number of contacts tested by test result and age/sex
Known Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Documented Negatives
Female
1-4
5-9
10-14
Male
1-4
5-9
10-14
DSD: HTS_TST (Facility) - PITC Modality: Inpatient Services
Required
REQUIRED IF ON PATH 2. PITC Inpatient Services Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
PITC Inpatient Services Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - PITC Modality: Pediatric Services
Required
REQUIRED IF ON PATH 2. PITC Pediatric Services (Under 5 or EPI) Disaggregated by Age / Result
Unknown Age
<1
1-4
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - PITC Modality: Malnutrition Clinics
Required
REQUIRED IF ON PATH 2. PITC Malnutrition Clinics Disaggregated by Age / Result
Unknown Age
<1
1-4
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: TB_STAT (Numerator)
Auto-Calculate
Number of new and relapsed TB cases with documented HIV status, during the reporting period. Numerator will auto-calculate from the Age/Sex/Result Disaggregates
Numerator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age / Sex / Result
Newly Tested Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
New Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Required
REQUIRED IF ON PATH 2. Disaggregated by Age / Sex / Result
Known Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Recently Tested Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
DSD: TB_STAT (Denominator)
Auto-Calculate
Total number of new and relapsed TB cases, during the reporting period. Denominator will auto-calculate from the Age/Sex Disaggregates
Denominator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age / Sex
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
DSD: HTS_TST (Facility) - PITC Modality: PMTCT Post ANC1: Pregnant/L&D
Required
REQUIRED IF ON PATH 2. Post ANC1: Pregnancy/L&D
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - PITC Modality: PMTCT Post ANC1: Breastfeeding
Required
REQUIRED IF ON PATH 2. Post ANC1: Breastfeeding
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - PITC Modality: STI Clinic
Required
REQUIRED IF ON PATH 2. STI Clinic Disaggregated by Age / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
STI Clinic Disaggregated by Age / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - PITC Modality: Emergency Ward
Required
REQUIRED IF ON PATH 2. Emergency Ward Disaggregated by Age / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
Emergency Ward Disaggregated by Age / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - PITC Modality: Other PITC
Required
REQUIRED IF ON PATH 2. Other PITC Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
Other PITC Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - SNS
Required
REQUIRED IF ON PATH 2. SNS Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
SNS Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
DSD: HTS_TST (Facility) - VCT
Required
REQUIRED IF ON PATH 2. VCT Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
VCT Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
Use Testing Path 2 below to enter HTS_TST results by modalities.
TA-SDI: HTS_TST (Facility)
Auto-Calculate
Number of individuals who received HIV Testing Services (HTS) and received their test results.
Numerator
Positive
TA-SDI: PMTCT_STAT (Numerator)
Auto-Calculate
Number of pregnant women with known HIV status at first antenatal care visit (ANC1) (includes those who already knew their HIV status prior to ANC1). Numerator will auto-calculate from the Status and Age Disaggregates.
Numerator
Required
REQUIRED IF ON PATH 2. Disaggregated by Status and Age
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Known Positives:
Newly Tested Positives:
New Negatives:
Recent Negatives:
Sub-total
TA-SDI: PMTCT_STAT (Denominator)
Auto-Calculate
Number of new ANC clients in reporting period. Denominator will auto-calculate from the Age Disaggregates.
Denominator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age (Fine Disaggregate)
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Sub-total
TA-SDI: HTS_INDEX (Facility)
Auto-Calculate
Number of individuals who were identified and tested using index testing services and received their results. Numerator auto-calculates from the sum of the Number of contacts tested by test result and age/sex.
Numerator
Optional
Number of index cases offered index testing services by age/sex
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Optional
Number of index cases that accepted index testing services by age/sex
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Optional
Number of contacts elicited by age/sex
Unknown
Age
Age
<15
15+
Female
Male
Sub-Total
Required
REQUIRED IF ON PATH 2. Number of contacts tested by test result and age/sex
Newly Tested Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
New Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Optional
Number of contacts tested by test result and age/sex
Known Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Documented Negatives
Female
1-4
5-9
10-14
Male
1-4
5-9
10-14
TA-SDI: HTS_TST (Facility) - PITC Modality: Inpatient Services
Required
REQUIRED IF ON PATH 2. PITC Inpatient Services Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
PITC Inpatient Services Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - PITC Modality: Pediatric Services
Required
REQUIRED IF ON PATH 2. PITC Pediatric Services (Under 5 or EPI) Disaggregated by Age / Result
Unknown Age
<1
1-4
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - PITC Modality: Malnutrition Clinics
Required
REQUIRED IF ON PATH 2. PITC Malnutrition Clinics Disaggregated by Age / Result
Unknown Age
<1
1-4
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: TB_STAT (Numerator)
Auto-Calculate
Number of new and relapsed TB cases with documented HIV status, during the reporting period. Numerator will auto-calculate from the Age/Sex/Result Disaggregates
Numerator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age / Sex / Result
Newly Tested Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
New Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Required
REQUIRED IF ON PATH 2. Disaggregated by Age / Sex / Result
Known Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Recently Tested Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
TA-SDI: TB_STAT (Denominator)
Auto-Calculate
Total number of new and relapsed TB cases, during the reporting period. Denominator will auto-calculate from the Age/Sex Disaggregates
Denominator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age / Sex
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
TA-SDI: HTS_TST (Facility) - PITC Modality: PMTCT Post ANC1: Pregnant/L&D
Required
REQUIRED IF ON PATH 2. Post ANC1: Pregnancy/L&D
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - PITC Modality: PMTCT Post ANC1: Breastfeeding
Required
REQUIRED IF ON PATH 2. Post ANC1: Breastfeeding
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - PITC Modality: STI Clinic
Required
REQUIRED IF ON PATH 2. STI Clinic Disaggregated by Age / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
STI Clinic Disaggregated by Age / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - PITC Modality: Emergency Ward
Required
REQUIRED IF ON PATH 2. Emergency Ward Disaggregated by Age / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
Emergency Ward Disaggregated by Age / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - PITC Modality: Other PITC
Required
REQUIRED IF ON PATH 2. Other PITC Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
Other PITC Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - SNS
Required
REQUIRED IF ON PATH 2. SNS Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
SNS Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
TA-SDI: HTS_TST (Facility) - VCT
Required
REQUIRED IF ON PATH 2. VCT Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
VCT Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
Use Testing Path 2 below to enter HTS_TST results by modalities.
CS: HTS_TST (Facility)
Auto-Calculate
Number of individuals who received HIV Testing Services (HTS) and received their test results.
Numerator
Positive
CS: PMTCT_STAT (Numerator)
Auto-Calculate
Number of pregnant women with known HIV status at first antenatal care visit (ANC1) (includes those who already knew their HIV status prior to ANC1). Numerator will auto-calculate from the Status and Age Disaggregates.
Numerator
Required
REQUIRED IF ON PATH 2. Disaggregated by Status and Age
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Known Positives:
Newly Tested Positives:
New Negatives:
Recent Negatives:
Sub-total
CS: PMTCT_STAT (Denominator)
Auto-Calculate
Number of new ANC clients in reporting period. Denominator will auto-calculate from the Age Disaggregates.
Denominator
Required
REQUIRED IF ON PATH 2. Disaggregated by Age (Fine Disaggregate)
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Sub-total
CS: HTS_TST (Facility) - Index Testing
Required
REQUIRED IF ON PATH 2. Number of contacts tested by test result and age/sex
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: Inpatient Services
Required
REQUIRED IF ON PATH 2. PITC Inpatient Services Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
PITC Inpatient Services Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: Pediatric Services
Required
REQUIRED IF ON PATH 2. PITC Pediatric Services (Under 5 or EPI) Disaggregated by Age / Result
Unknown Age
<1
1-4
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: Malnutrition Clinics
Required
REQUIRED IF ON PATH 2. PITC Malnutrition Clinics Disaggregated by Age / Result
Unknown Age
<1
1-4
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: TB Clinics
Required
REQUIRED IF ON PATH 2. Number of new and relapsed TB cases with documented HIV status, during the reporting period. Disaggregated by Age/Sex/Result.
Newly Tested Positives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
New Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Recently Tested Negatives
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
CS: HTS_TST (Facility) - PITC Modality: PMTCT Post ANC1: Pregnant/L&D
Required
REQUIRED IF ON PATH 2. Post ANC1: Pregnancy/L&D
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: PMTCT Post ANC1: Breastfeeding
Required
REQUIRED IF ON PATH 2. Post ANC1: Breastfeeding
Unknown
Age
Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: STI Clinic
Required
REQUIRED IF ON PATH 2. STI Clinic Disaggregated by Age / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
STI Clinic Disaggregated by Age / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: Emergency Ward
Required
REQUIRED IF ON PATH 2. Emergency Ward Disaggregated by Age / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
Emergency Ward Disaggregated by Age / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - PITC Modality: Other PITC
Required
REQUIRED IF ON PATH 2. Other PITC Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
Other PITC Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - SNS
Required
REQUIRED IF ON PATH 2. SNS Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
SNS Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
CS: HTS_TST (Facility) - VCT
Required
REQUIRED IF ON PATH 2. VCT Disaggregated by Age / Sex / Result (Fine Disaggregate)
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
F
M
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
25-29
30-34
35-39
40-44
45-49
50+
F
M
F
M
F
M
F
M
F
M
F
M
Positive
Negative
Sub-total
Conditional
VCT Disaggregated by Age / Sex / Result (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown Age
<15
15+
F
M
F
M
F
M
Positive
Negative
Sub-total
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
DSD: HTS_SELF
Auto-Calculate
Number of individual HIV self-test kits distributed. Numerator will auto-calculate from the directly-assisted/unassisted self-testing types. HTS_SELF is not reported under HTS_TST (or HTS_TST_POS) results.
Numerator
Optional
Enter the number of self-test kits distributed for directly assisted testing. Disaggregated by Directly Assisted / Age / Sex.
Unknown
Age
Age
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Subtotal:
Optional
Enter the number of self-test kits distributed for unassisted testing. Disaggregated by Unassisted /Age/ Sex.
Unknown
Age
Age
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Subtotal:
Optional
Disaggregate of Unassisted self-testing kits distributed. Enter the number of unassisted self-test kits distributed for use by:
Self
Sex Partner
Caregiver for Child
Other
Unassisted self-testing kit used by:
DSD: PMTCT_EID
Auto-Calculate
Number of HIV-exposed infants who had a virologic HIV test (sample collected) by 12 months of birth during the reporting period. Numerator will auto-calculate from infant age at first test.
Numerator
Required
Disaggregated by infant age at test.
0 ≤ 2 Months
2 - 12 Months
First Test
Second Test or more
DSD: PMTCT_HEI
Auto-Calculate
Number of HIV-infected infants identified in the reporting period, whose diagnostic sample was collected by 12 months of age. Numerator will auto-calculate from the HIV-infected infant age and result returned disaggregation.
Numerator
Required
Disaggregated by infant age at virologic sample collection and result returned.
0 ≤ 2 Months
2 - 12 Months
Result, Positive
Result, Negative
Required
Disaggregated by result returned, Positive, confirmed initiated ART by age at virologic sample collection.
0 ≤ 2 Months
2 - 12 Months
Positive, confirmed initiated ART
DSD: CXCA_SCRN
Auto-Calculate
Number of HIV-positive women on ART screened for cervical cancer. Numerator will auto-calculate from the Age/Result/Screening Visit Type
Numerator
Optional
Disaggregated by Age/Result/Screening Visit Type
First time screened for cervical cancer
Cervical Cancer screen: Negative
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Positive
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Suspected Cancer
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Rescreened after previous negative or suspected cancer
Cervical Cancer screen: Negative
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Positive
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Suspected Cancer
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Post-treatment follow-up
Cervical Cancer screen: Negative
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Positive
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Suspected Cancer
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
DSD: OVC_HIVSTAT
Auto-Calculate
Number of orphans and vulnerable children enrolled in the OVC Comprehensive program with HIV status reported. Numerator will auto-calculate from Status Type Disaggregate.
Numerator
Optional
Disaggregated by Age/Sex/Status Type
Reported HIV positive to IP
Of those positive: Currently receiving ART
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
Of those positive: Not Currently receiving ART or ART Status Unknown
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
Reported HIV Negative to IP
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
Test not required based on risk assessment
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
No HIV status reported to the IP (HIV Status Unknown)
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
DSD: PMTCT_FO
Optional
Number of HIV-exposed infants who were born 24 months prior to the reporting period and registered in the birth cohort.
Denominator
Auto-Calculate
Number of HIV-exposed infants with a documented outcome by 18 months of age disaggregated by outcome type. Numerator will auto-calculate from the Outcome Type Disaggregate.
Numerator
Optional
Numerator: Disaggregated by Outcome Type
HIV-infected
HIV-uninfected
HIV-final status unknown
Died without status known
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
TA-SDI: HTS_SELF
Auto-Calculate
Number of individual HIV self-test kits distributed. Numerator will auto-calculate from the directly-assisted/unassisted self-testing types. HTS_SELF is not reported under HTS_TST (or HTS_TST_POS) results.
Numerator
Optional
Enter the number of self-test kits distributed for directly assisted testing. Disaggregated by Directly Assisted / Age / Sex.
Unknown
Age
Age
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Subtotal:
Optional
Enter the number of self-test kits distributed for unassisted testing. Disaggregated by Unassisted /Age/ Sex.
Unknown
Age
Age
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Female
Male
Subtotal:
Optional
Disaggregate of Unassisted self-testing kits distributed. Enter the number of unassisted self-test kits distributed for use by:
Self
Sex Partner
Caregiver for Child
Other
Unassisted self-testing kit used by:
TA-SDI: PMTCT_EID
Auto-Calculate
Number of HIV-exposed infants who had a virologic HIV test (sample collected) by 12 months of birth during the reporting period. Numerator will auto-calculate from infant age at first test.
Numerator
Required
Disaggregated by infant age at test.
0 ≤ 2 Months
2 - 12 Months
First Test
Second Test or more
TA-SDI: PMTCT_HEI
Auto-Calculate
Number of HIV-infected infants identified in the reporting period, whose diagnostic sample was collected by 12 months of age. Numerator will auto-calculate from the HIV-infected infant age and result returned disaggregation.
Numerator
Required
Disaggregated by infant age at virologic sample collection and result returned.
0 ≤ 2 Months
2 - 12 Months
Result, Positive
Result, Negative
Required
Disaggregated by result returned, Positive, confirmed initiated ART by age at virologic sample collection.
0 ≤ 2 Months
2 - 12 Months
Positive, confirmed initiated ART
TA-SDI: CXCA_SCRN
Auto-Calculate
Number of HIV-positive women on ART screened for cervical cancer. Numerator will auto-calculate from the Age/Result/Screening Visit Type
Numerator
Optional
Disaggregated by Age/Result/Screening Visit Type
First time screened for cervical cancer
Cervical Cancer screen: Negative
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Positive
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Suspected Cancer
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Rescreened after previous negative or suspected cancer
Cervical Cancer screen: Negative
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Positive
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Suspected Cancer
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Post-treatment follow-up
Cervical Cancer screen: Negative
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Positive
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
Cervical Cancer screen: Suspected Cancer
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50+
TA-SDI: OVC_HIVSTAT
Auto-Calculate
Number of orphans and vulnerable children enrolled in the OVC Comprehensive program with HIV status reported. Numerator will auto-calculate from Status Type Disaggregate.
Numerator
Optional
Disaggregated by Age/Sex/Status Type
Reported HIV positive to IP
Of those positive: Currently receiving ART
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
Of those positive: Not Currently receiving ART or ART Status Unknown
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
Reported HIV Negative to IP
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
Test not required based on risk assessment
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
No HIV status reported to the IP (HIV Status Unknown)
Unknown
Age
Age
<1
1-4
5-9
10-14
15-17
18-20
Female
Male
TA-SDI: PMTCT_FO
Optional
Number of HIV-exposed infants who were born 24 months prior to the reporting period and registered in the birth cohort.
Denominator
Auto-Calculate
Number of HIV-exposed infants with a documented outcome by 18 months of age disaggregated by outcome type. Numerator will auto-calculate from the Outcome Type Disaggregate.
Numerator
Optional
Numerator: Disaggregated by Outcome Type
HIV-infected
HIV-uninfected
HIV-final status unknown
Died without status known
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
DSD: TX_NEW
Auto-Calculate
Number of adults and children newly enrolled on antiretroviral therapy (ART). Numerator will auto-calculate from Age/Sex Disaggregates
Numerator
Required
Disaggregated by Age/Sex and CD4: If TX_NEW data cannot be disaggregated by CD4 count, enter all TX_NEW data in the 'Unknown CD4' disaggregate.
<200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
≥200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Unknown CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+) / Sex
<200 CD4
50+
Female
Male
≥200 CD4
50+
Female
Male
Unknown CD4
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
<200 CD4
Unknown
Age
Age
<15
15+
Female
Male
≥200 CD4
Unknown
Age
Age
<15
15+
Female
Male
Unknown CD4
Unknown
Age
Age
<15
15+
Female
Male
Required
Disaggregated by Breastfeeding Status at ART initiation
Breastfeeding
DSD: TX_CURR
Auto-Calculate
Number of adults and children currently receiving antiretroviral therapy (ART). Numerator will auto-calculate from Age/Sex Disaggregates.
Numerator
Required
Disaggregated by Age / Sex (Fine Disaggregate)
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
Female
Male
45-49
50-54
55-59
60-64
65+
Female
Male
Conditional
Disaggregated by Age / Sex (Fine Disaggregate)
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-Total
Required
Disaggregated by ARV Dispensing Quantity by Coarse Age/Sex
<3 months of ARVs (not MMD)
3-5 months of ARVs
6 or more months of ARVs
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
DSD: TX_RTT
Auto-Calculate
Number of ART patients who experienced an interruption in treatment (IIT) during any previous reporting period, who successfully restarted ARVs within the reporting period and remained on treatment until the end of the reporting period. The Numerator will auto-calculate from Age/Sex Disaggregates.
Numerator
Optional
Disaggregated by Age/Sex and CD4
<200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
≥200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Unknown CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Not Eligible for CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+) / Sex
<200 CD4
50+
Female
Male
≥200 CD4
50+
Female
Male
Unknown CD4
50+
Female
Male
Not Eligible for CD4
50+
Female
Male
Optional
Disaggregated by IIT
Experienced treatment interruption of <3 months before returning to treatment
Experienced treatment interruption of 3-5 months before returning to treatment
Experienced treatment interruption of 6+ months before returning to treatment
DSD: TX_ML
Auto-Calculate
Number of ART patients who were on ART at the beginning of the quarterly reporting period or initiated treatment during the reporting period and then had no clinical contact since their last expected contact. The numerator auto-calculates from the sum of Age/Sex Outcome
Numerator
Required
Disaggregated Outcome by Age/Sex
Died
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Interruption in Treatment After being on Treatment for < 3 months
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Interruption in Treatment After being on Treatment for 3-5 months
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Interruption in Treatment After being on Treatment for 6+ months
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Transferred Out
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Refused (Stopped) Treatment
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Optional
Disaggregated Outcome by Cause of Death by Age/Sex
HIV disease resulting in TB
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
HIV disease resulting in cancer
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
HIV disease resulting in other infectious and parasitic disease
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Other HIV disease, resulting in other diseases or conditions leading to death
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Other natural causes
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Non-natural causes
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Unknown cause
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
DSD: PMTCT_ART
Auto-Calculate
Number of HIV-positive pregnant women who received ART to reduce the risk of mother-to-child-transmission during pregnancy. Numerator will auto-calculate from the Maternal Regimen Type Disaggregates.
Numerator
Required
Disaggregated by Regimen Type:
New on ART
Unknown Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Already on ART at the beginning of current pregnancy
Unknown Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
New on ART
Already on ART at the beginning of current pregnancy
DSD: TX_TB (Numerator)
Auto-Calculate
Number of ART patients who were started on TB treatment during the reporting period. Numerator will auto-calculate from Already/New on ART by Age/Sex
Numerator
Required
Disaggregated by Already/New on ART by Age/Sex
The number of patients starting TB treatment who newly started ART during reporting period
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
The number of patients starting TB treatment who were already on ART prior to the start of the reporting period
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Female
Male
Unknown Age
<15
15+
Unknown Age
<15
15+
The number of patients starting TB treatment who newly started ART during the reporting period
The number of patients starting TB treatment who were already on ART prior to the start of the reporting period
Sub-total
DSD: TX_TB (Denominator)
Auto-Calculate
Number of ART patients who were screened for TB at least once during the reporting period. Denominator will auto-calculate from Start on ART by Screen Result by Age/Sex
Denominator
Required
Disaggregated by Start of ART by Screen Result by Age/Sex
New on ART/Screen Positive
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
New on ART/Screen Negative
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Already on ART/Screen Positive
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Already on ART/Screen Negative
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Newly enrolled on ART
Previously Enrolled on ART
Female
Male
Female
Male
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Screen Positive
Screen Negative
Sub-total
Optional
Disaggregated by Screen Type
Number of patients who had a TB screening by Screening Type
Symptom Screen Only
Chest X-Ray
Molecular WHO-Recommended Diagnostic Test(mWRD)
Optional
Disaggregated by Specimen Sent
Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease
Optional
[Disagg of Specimen Sent] Diagnostic Test
Number of patients whose specimens were sent for the following diagnostic tests:
Smear Microscopy Only
mWRD: Molecular WHO-Recommended Diagnostic PCR (with or without other testing)
Additional test other than mWRD
Optional
Disaggregated by Positive Result Returned
Number of ART patients who had a positive result returned for bacteriologic diagnosis of active TB disease
DSD: CXCA_TX
Auto-Calculate
Number of women with a positive VIA screening test who are HIV-positive and on ART eligible for cryotherapy, thermocoagulation or LEEP who received cryotherapy, thermocoagulation or LEEP. Numerator will auto-calculate from the Age/Treatment Type/Screening Visit Type.
Numerator
Optional
Disaggregated by Age/Treatment Type/Screening Visit Type
First time screened for cervical cancer
Cryotherapy
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
LEEP
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Thermocoagulation
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
Cryotherapy
LEEP
Thermocoagulation
Rescreened after previous negative or suspected cancer
Cryotherapy
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
LEEP
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Thermocoagulation
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
Cryotherapy
LEEP
Thermocoagulation
Post-treatment follow-up
Cryotherapy
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
LEEP
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Thermocoagulation
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
Cryotherapy
LEEP
Thermocoagulation
DSD: TB_ART (Numerator)
Auto-Calculate
Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period. Numerator will auto-calculate from Age/Sex/Result Disaggregates
Numerator
Optional
Disaggregated by Age/Sex/Result
Already on ART
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
New on ART
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
TA-SDI: TX_NEW
Auto-Calculate
Number of adults and children newly enrolled on antiretroviral therapy (ART). Numerator will auto-calculate from Age/Sex Disaggregates
Numerator
Required
Disaggregated by Age/Sex and CD4: If TX_NEW data cannot be disaggregated by CD4 count, enter all TX_NEW data in the 'Unknown CD4' disaggregate.
<200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
≥200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Unknown CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+) / Sex
<200 CD4
50+
Female
Male
≥200 CD4
50+
Female
Male
Unknown CD4
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
<200 CD4
Unknown
Age
Age
<15
15+
Female
Male
≥200 CD4
Unknown
Age
Age
<15
15+
Female
Male
Unknown CD4
Unknown
Age
Age
<15
15+
Female
Male
Required
Disaggregated by Breastfeeding Status at ART initiation
Breastfeeding
TA-SDI: TX_CURR
Auto-Calculate
Number of adults and children currently receiving antiretroviral therapy (ART). Numerator will auto-calculate from Age/Sex Disaggregates.
Numerator
Required
Disaggregated by Age / Sex (Fine Disaggregate)
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
Female
Male
45-49
50-54
55-59
60-64
65+
Female
Male
Conditional
Disaggregated by Age / Sex (Fine Disaggregate)
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-Total
Required
Disaggregated by ARV Dispensing Quantity by Coarse Age/Sex
<3 months of ARVs (not MMD)
3-5 months of ARVs
6 or more months of ARVs
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
TA-SDI: TX_RTT
Auto-Calculate
Number of ART patients who experienced an interruption in treatment (IIT) during any previous reporting period, who successfully restarted ARVs within the reporting period and remained on treatment until the end of the reporting period. The Numerator will auto-calculate from Age/Sex Disaggregates.
Numerator
Optional
Disaggregated by Age/Sex and CD4
<200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
≥200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Unknown CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Not Eligible for CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+) / Sex
<200 CD4
50+
Female
Male
≥200 CD4
50+
Female
Male
Unknown CD4
50+
Female
Male
Not Eligible for CD4
50+
Female
Male
Optional
Disaggregated by IIT
Experienced treatment interruption of <3 months before returning to treatment
Experienced treatment interruption of 3-5 months before returning to treatment
Experienced treatment interruption of 6+ months before returning to treatment
TA-SDI: TX_ML
Auto-Calculate
Number of ART patients who were on ART at the beginning of the quarterly reporting period or initiated treatment during the reporting period and then had no clinical contact since their last expected contact. The numerator auto-calculates from the sum of Age/Sex Outcome
Numerator
Required
Disaggregated Outcome by Age/Sex
Died
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Interruption in Treatment After being on Treatment for < 3 months
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Interruption in Treatment After being on Treatment for 3-5 months
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Interruption in Treatment After being on Treatment for 6+ months
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Transferred Out
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Refused (Stopped) Treatment
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Optional
Disaggregated Outcome by Cause of Death by Age/Sex
HIV disease resulting in TB
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
HIV disease resulting in cancer
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
HIV disease resulting in other infectious and parasitic disease
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Other HIV disease, resulting in other diseases or conditions leading to death
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Other natural causes
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Non-natural causes
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
Unknown cause
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Female
Male
Sub-total
Conditional
Age (50+) / Sex
50+
Female
Male
TA-SDI: PMTCT_ART
Auto-Calculate
Number of HIV-positive pregnant women who received ART to reduce the risk of mother-to-child-transmission during pregnancy. Numerator will auto-calculate from the Maternal Regimen Type Disaggregates.
Numerator
Required
Disaggregated by Regimen Type:
New on ART
Unknown Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Already on ART at the beginning of current pregnancy
Unknown Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
New on ART
Already on ART at the beginning of current pregnancy
TA-SDI: TX_TB (Numerator)
Auto-Calculate
Number of ART patients who were started on TB treatment during the reporting period. Numerator will auto-calculate from Already/New on ART by Age/Sex
Numerator
Required
Disaggregated by Already/New on ART by Age/Sex
The number of patients starting TB treatment who newly started ART during reporting period
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
The number of patients starting TB treatment who were already on ART prior to the start of the reporting period
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Female
Male
Unknown Age
<15
15+
Unknown Age
<15
15+
The number of patients starting TB treatment who newly started ART during the reporting period
The number of patients starting TB treatment who were already on ART prior to the start of the reporting period
Sub-total
TA-SDI: TX_TB (Denominator)
Auto-Calculate
Number of ART patients who were screened for TB at least once during the reporting period. Denominator will auto-calculate from Start on ART by Screen Result by Age/Sex
Denominator
Required
Disaggregated by Start of ART by Screen Result by Age/Sex
New on ART/Screen Positive
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
New on ART/Screen Negative
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Already on ART/Screen Positive
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Already on ART/Screen Negative
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Newly enrolled on ART
Previously Enrolled on ART
Female
Male
Female
Male
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Screen Positive
Screen Negative
Sub-total
Optional
Disaggregated by Screen Type
Number of patients who had a TB screening by Screening Type
Symptom Screen Only
Chest X-Ray
Molecular WHO-Recommended Diagnostic Test(mWRD)
Optional
Disaggregated by Specimen Sent
Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease
Optional
[Disagg of Specimen Sent] Diagnostic Test
Number of patients whose specimens were sent for the following diagnostic tests:
Smear Microscopy Only
mWRD: Molecular WHO-Recommended Diagnostic PCR (with or without other testing)
Additional test other than mWRD
Optional
Disaggregated by Positive Result Returned
Number of ART patients who had a positive result returned for bacteriologic diagnosis of active TB disease
TA-SDI: CXCA_TX
Auto-Calculate
Number of women with a positive VIA screening test who are HIV-positive and on ART eligible for cryotherapy, thermocoagulation or LEEP who received cryotherapy, thermocoagulation or LEEP. Numerator will auto-calculate from the Age/Treatment Type/Screening Visit Type.
Numerator
Optional
Disaggregated by Age/Treatment Type/Screening Visit Type
First time screened for cervical cancer
Cryotherapy
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
LEEP
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Thermocoagulation
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
Cryotherapy
LEEP
Thermocoagulation
Rescreened after previous negative or suspected cancer
Cryotherapy
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
LEEP
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Thermocoagulation
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
Cryotherapy
LEEP
Thermocoagulation
Post-treatment follow-up
Cryotherapy
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
LEEP
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Thermocoagulation
Unknown
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
Cryotherapy
LEEP
Thermocoagulation
TA-SDI: TB_ART (Numerator)
Auto-Calculate
Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period. Numerator will auto-calculate from Age/Sex/Result Disaggregates
Numerator
Optional
Disaggregated by Age/Sex/Result
Already on ART
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
New on ART
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Age (50+) / Sex
50+
Female
Male
CS: TX_NEW
Auto-Calculate
Number of adults and children newly enrolled on antiretroviral therapy (ART). Numerator will auto-calculate from Age/Sex Disaggregates
Numerator
Required
Disaggregated by Age/Sex and CD4: If TX_NEW data cannot be disaggregated by CD4 count, enter all TX_NEW data in the 'Unknown CD4' disaggregate.
<200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
≥200 CD4
Female
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Unknown CD4
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+) / Sex
<200 CD4
50+
Female
Male
≥200 CD4
50+
Female
Male
Unknown CD4
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
<200 CD4
Unknown
Age
Age
<15
15+
Female
Male
≥200 CD4
Unknown
Age
Age
<15
15+
Female
Male
Unknown CD4
Unknown
Age
Age
<15
15+
Female
Male
Required
Disaggregated by Breastfeeding Status at ART initiation
Breastfeeding
CS: TX_CURR
Auto-Calculate
Number of adults and children currently receiving antiretroviral therapy (ART). Numerator will auto-calculate from Age/Sex Disaggregates.
Numerator
Required
Disaggregated by Age / Sex (Fine Disaggregate)
Unknown
Age
Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
Female
Male
45-49
50-54
55-59
60-64
65+
Female
Male
Conditional
Disaggregated by Age / Sex (Fine Disaggregate)
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate) - USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-Total
Required
Disaggregated by ARV Dispensing Quantity by Coarse Age/Sex
<3 months of ARVs (not MMD)
3-5 months of ARVs
6 or more months of ARVs
Unknown Age
<15
15+
Unknown Age
<15
15+
Unknown Age
<15
15+
Female
Male
CS: PMTCT_ART
Auto-Calculate
Number of HIV-positive pregnant women who received ART to reduce the risk of mother-to-child-transmission during pregnancy. Numerator will auto-calculate from the Maternal Regimen Type Disaggregates.
Numerator
Required
Disaggregated by Regimen Type:
New on ART
Unknown Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Already on ART at the beginning of current pregnancy
Unknown Age
<10
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Conditional
Age (50+)
50+
New on ART
Already on ART at the beginning of current pregnancy
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
DSD: TX_PVLS (Numerator)
Auto-Calculate
Adult and Pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. Numerator will auto-calculate from the sum of the Age/Sex disaggregates.
Numerator
Required
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate). USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-total
Required
Disaggregated by Pregnant/Breastfeeding. Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
DSD: TX_PVLS (Denominator)
Auto-Calculate
Adult and Pediatric ART patients with a viral load result documented in the medical records and/or supporting laboratory results within the past 12 months. Denominator will auto-calculate from the sum of the Age/Sex disaggregates.
Denominator
Required
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate). USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-total
Required
Disaggregated by Pregnant/Breastfeeding. Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
If MER Results data is unable to be disaggregated by DSD or TA support type, please report ALL data under the TA Support Type.
TA-SDI: TX_PVLS (Numerator)
Auto-Calculate
Adult and Pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. Numerator will auto-calculate from the sum of the Age/Sex disaggregates.
Numerator
Required
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate). USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-total
Required
Disaggregated by Pregnant/Breastfeeding. Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
TA-SDI: TX_PVLS (Denominator)
Auto-Calculate
Adult and Pediatric ART patients with a viral load result documented in the medical records and/or supporting laboratory results within the past 12 months. Denominator will auto-calculate from the sum of the Age/Sex disaggregates.
Denominator
Required
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate). USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-total
Required
Disaggregated by Pregnant/Breastfeeding. Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
CS: TX_PVLS (Numerator)
Auto-Calculate
Adult and Pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. Numerator will auto-calculate from the sum of the Age/Sex disaggregates.
Numerator
Required
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate). USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-total
Required
Disaggregated by Pregnant/Breastfeeding. Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
CS: TX_PVLS (Denominator)
Auto-Calculate
Adult and Pediatric ART patients with a viral load result documented in the medical records and/or supporting laboratory results within the past 12 months. Denominator will auto-calculate from the sum of the Age/Sex disaggregates.
Denominator
Required
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program.
Female
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Male
Unknown Age
<1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65+
Subtotal:
Conditional
Disaggregated by Age / Sex (Fine Disaggregate). Must complete finer disaggregates unless permitted by program
50+
Female
Male
Conditional
Disaggregated by Age / Sex (Coarse Disaggregate). USE WITH HQ PERMISSION ONLY
Unknown
Age
Age
<15
15+
Female
Male
Sub-total
Required
Disaggregated by Pregnant/Breastfeeding. Data on Pregnant/Breastfeeding individuals should be reported in both the "Disaggregated by Pregnant/Breastfeeding" section and the "Disaggregated by Age/Sex" section.
Pregnant
Breastfeeding
SC_ARVDISP
Optional
The number of adult and pediatric ARV bottles (units) dispensed by ARV drug category at the end of the reporting period
Disaggregated by Drug Categories
TLD
TLD 30-count bottles
TLD 90-count bottles
TLD 180-count bottles
TLE
TLE/400 30-count bottles
TLE/400 90-count bottles
TLE 600/TEE bottles
LPV
LPV/r 40/10 (Pediatrics) bottles
LPV/r 100/25 tabs (Pediatrics) (60 tabs/bottle)
DTG
DTG 10 (Pediatrics, 90-count)
NVP
NVP (Adult) bottles
NVP (Pediatric) bottles
Other
Other (Adult) bottles
Other (Pediatric) bottles
LAB_PTCQI (Lab-based)
Optional
Enter the number of PEPFAR supported laboratory based sites performing the following tests and their current CQI status at this facility.
How many sites perform this test but do not participate in CQI?
How many sites perform this test, participate in CQI, but are not fully accredited?
How many sites perform this test, participate in CQI, & are fully accredited?
Auto Sum total number of sites
HIV Serology/Diagnostic Testing
HIV IVT/EID
HIV Viral Load
TB mWRD
TB LF-LAM
TB AFB
TB Culture
CD4
Rapid Test for Recent Infection
Optional
Enter the number of PEPFAR supported laboratory based sites performing the following tests and their current PT status at this facility.
How many sites performed this test but do not participate in PT?
How many sites perform this test and participate in PT?
Auto Sum total number of sites
HIV Serology/Diagnostic Testing
HIV IVT/EID
HIV Viral Load
TB mWRD
TB LF-LAM
TB AFB
TB Culture
CD4
Rapid Test for Recent Infection
Optional
Enter the number of specimens received for testing at all PEPFAR-supported laboratory-based testing sites within a testing category:
HIV Serology/Diagnostic Testing
HIV IVT/EID
HIV Viral Load
TB mWRD
TB LF-LAM
TB AFB
TB Culture
CD4
Rapid Test for Recent Infection
Specimens received
LAB_PTCQI (POCT-based)
Optional
Enter the number of PEPFAR supported sites performing the following tests and their current CQI status at this facility.
How many sites perform this test but do not participate in CQI?
How many sites perform this test, participate in CQI, but are not fully certified/accredited?
How many sites perform this test, participate in CQI, & are fully certified/accredited?
Auto Sum total number of sites
HIV Serology/Diagnostic Testing
HIV IVT/EID
HIV Viral Load
TB mWRD
TB LF-LAM
TB AFB
CD4
Rapid Test for Recent Infection
Optional
Enter the number of PEPFAR supported sites performing the following tests and their current PT status at this facility.
How many sites perform this test but do not participate in PT?
How many sites perform this test and participate in PT?
Auto Sum total number of sites
HIV Serology/Diagnostic Testing
HIV IVT/EID
HIV Viral Load
TB mWRD
TB LF-LAM
TB AFB
CD4
Rapid Test for Recent Infection
Optional
Enter the number of specimens received for testing at all PEPFAR-supported POCT sites within a testing category:
HIV Serology/Diagnostic Testing
HIV IVT/EID
HIV Viral Load
TB mWRD
TB LF-LAM
TB AFB
CD4
Rapid Test for Recent Infection
Specimens received
|
Are you sure you want to delete this file?